Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained roughly 46% in the past one-month time frame.
This biopharmaceutical company has witnessed two positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Agios Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Investors interested in the medical products industry may consider stocks like ICU Medical, Inc. (ICUI), OraSure Technologies, Inc. (OSUR) and Abaxis, Inc. (ABAX). While ICU Medical and OraSure sport a Zacks Rank #1 (Strong Buy), Abaxis holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AGIOS PHARMACEUTICALS INC (AGIO): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
ORASURE TECHNOLOGIES INC (OSUR): Free Stock Analysis Report
ABAXIS CP (ABAX): Free Stock Analysis Report
Zacks Investment Research